LXRX Q2 2019 Earnings — Lexicon Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

LXRXLexicon Pharmaceuticals, Inc.

$693M

Q2 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$10M-29.6% YoY

Gross Profit

$8M86.3% margin

Operating Income

-$19M-191.5% margin

Net Income

-$23M-237.7% margin

EPS (Diluted)

$-0.22

QoQ Revenue Growth

+5.1%

Cash Flow

Operating Cash Flow

-$27M

Free Cash Flow

-$27M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$233M

Total Liabilities

$298M

Stockholders' Equity

-$65M

Cash & Equivalents

$106M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$14M	-29.6%
Gross Profit	$8M	$13M	-35.3%
Operating Income	-$19M	-$30M	+39.1%
Net Income	-$23M	-$35M	+33.7%